Perrigo’s Albuterol Advantage Blunted By Recall

ProAir Rival Sees ‘Clogging’ Complaints; Cipla And Lupin Also Have Generic Albuterol

 
• By Dave Wallace

After a high-profile launch early this year, first-mover Perrigo has recalled its albuterol sulfate aerosol in the US following complaints of inhalers failing to dispense due to “clogging.” The firm has revealed the expected financial impact of the move as well as commenting on how long it expects the product to be off the market, during which albuterol rivals Cipla and Lupin could benefit.

Product_Recall
Perrigo is recalling its albuterol sulfate aerosol in the US • Source: Shutterstock

Perrigo has recalled its version of Teva’s ProAir HFA (albuterol sulfate) inhaler in the US, following a high-profile first generic launch early this year. The move came “as a result of complaints that some units may not dispense due to clogging,” the company announced, adding that it expects to register a significant third-quarter impairment linked to the recall.

Referring to the action as a “voluntary US nationwide recall of albuterol sulfate inhalation aerosol to the retail level,” Perrigo revealed that the recall had followed the firm “previously halting production and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Products